(Q72360950)

English

Initial experience with hirudin and streptokinase in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 6 trial

scientific article published on 01 January 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7801868%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Initial experience with hirudin and streptokinase in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 6 trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7801868%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

L V Lee

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7801868%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

language of work or name

0 references

publication date

1 January 1995

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7801868%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

American Journal of Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7801868%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

75

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7801868%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7801868%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

7-13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7801868%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Enhancing thrombolytic efficacy by means of "front-loaded" administration of tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

Effect of thrombin inhibition on the dynamics of thrombolysis and on platelet function during thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

Biology of recombinant hirudin (CGP 39393): a new prospect in the treatment of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

Comparison of hirudin and heparin as adjuncts to streptokinase thrombolysis in a canine model of coronary thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

Recombinant hirudin in patients with chronic, stable coronary artery disease. Safety, half-life, and effect on coagulation parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

A pilot, early angiographic patency study using a direct thrombin inhibitor as adjunctive therapy to streptokinase in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

Reactivation of unstable angina after the discontinuation of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980517-7

7 January 2021

Identifiers

10.1016/S0002-9149(99)80517-7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7801868%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7801868%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q72360950&oldid=1940417319"